Search
Showing results for "1"
Research
RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort studyThe monoclonal antibody, palivizumab is licensed for use in high-risk infants to prevent severe illness caused by respiratory syncytial virus (RSV). The level of its use and compliance with current jurisdictional guidelines which were amended in 2010, is unknown.
Research
Genetics, Transcriptomics and Meta-Taxonomics in Visceral LeishmaniasisVisceral leishmaniasis (VL) caused by parasites of the Leishmania donovani complex can be fatal in susceptible individuals. Understanding the interactions between host and pathogen is one way to obtain leads to develop better drugs and for vaccine development. In recent years multiple omics-based approaches have assisted researchers to gain a more global picture of this interaction in leishmaniasis. Here we review results from studies using three omics-based approaches to study VL caused by L. donovani in India.
Research
A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis in BrazilOur goal was to identify genetic risk factors for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.
Research
Prospective surveillance of primary healthcare presentations for scabies and bacterial skin infections in Fiji, 2018-2019Scabies, impetigo, and other skin and soft tissue infections (SSTIs) are highly prevalent in many tropical, low-middle income settings, but information regarding their burden of disease is scarce. We conducted surveillance of presentations of scabies and SSTIs, including impetigo, abscesses, cellulitis, and seāvere SSTI, to primary health facilities in Fiji.
News & Events
Launching DiabHQ app this World Diabetes DayInnovative new digital platform set to transform diabetes care for WA families.
News & Events
New research on youth-onset type 2 diabetes in northern AustraliaExplore new research on youth-onset diabetes at The Kids' Institute, uncovering insights to improve health outcomes for young patients in Northern Australia.
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au Respiratory Syncytial
Strengths-based, tiered, accessible, resources and supports (STARS) for Kids for parent, carers and their children.
News & Events
Telehealth can support families with their goalsIn this blog, Speech Pathology Clinical Lead Aria May looks at telehealth and how it can support children and families with their therapy goals.
In 2014, Wesfarmers committed $5 million over 4 years to The Kids' research to set up the Wesfarmers Centre of Vaccines and Infectious Diseases.